These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Characterization of a chromosomal nickel resistance determinant from Klebsiella oxytoca CCUG 15788. Park JS; Lee SJ; Rhie HG; Lee HS J Microbiol Biotechnol; 2008 Jun; 18(6):1040-3. PubMed ID: 18600044 [TBL] [Abstract][Full Text] [Related]
12. Genetic Diversity of KPC-Producing Escherichia coli, Klebsiella oxytoca, Serratia marcescens, and Citrobacter freundii Isolates from Argentina. De Belder D; Lucero C; Rapoport M; Rosato A; Faccone D; Petroni A; Pasteran F; Albornoz E; Corso A; Gomez SA Microb Drug Resist; 2018 Sep; 24(7):958-965. PubMed ID: 29236574 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the cytosolic DnaJ homologue, YDJ1, delay and compromise the efficient translation of heterologous proteins in yeast. Brodsky JL; Lawrence JG; Caplan AJ Biochemistry; 1998 Dec; 37(51):18045-55. PubMed ID: 9922173 [TBL] [Abstract][Full Text] [Related]
14. Expression of Escherichia coli recA and ada genes in Saccharomyces cerevisiae using a vector with geneticin resistance. Slaninová M; Farkasová E; Chovanec M; Vlcková V; Näslund M; Henriques JA; Brozmanová J Folia Microbiol (Praha); 1995; 40(3):257-62. PubMed ID: 8919931 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings. Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292 [TBL] [Abstract][Full Text] [Related]
16. Protein expression enhancement in efflux-deleted mutant bacteria. Le TT; Guet CC; Cluzel P Protein Expr Purif; 2006 Jul; 48(1):28-31. PubMed ID: 16403646 [TBL] [Abstract][Full Text] [Related]
17. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan. Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of aztreonam against Escherichia coli and Klebsiella oxytoca: defining pharmacodynamic targets. Noel AR; Attwood M; Bowker KE; MacGowan AP J Antimicrob Chemother; 2020 Mar; 75(3):772-773. PubMed ID: 31848597 [No Abstract] [Full Text] [Related]
19. Functional genetic expression of eukaryotic DNA in Escherichia coli. 1976. Struhl K; Cameron JR; Davis RW Biotechnology; 1992; 24():353-7. PubMed ID: 1422039 [No Abstract] [Full Text] [Related]
20. Expression in Escherichia coli of a recombinant adenosine kinase from Saccharomyces cerevisiae: purification, kinetics and substrate analyses. Barrado P; Rodríguez MJ; Jiménez A; Fernández Lobato M Yeast; 2003 Oct; 20(13):1145-50. PubMed ID: 14558146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]